Q Therapeutics Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Q Therapeutics General Information
Description
Developer of novel stem cell therapy intended to treat debilitating CNS disease and injury. The company's cell therapies replace the insulating myelin on damaged neurons and provide trophic support for restoring and preserving normal functions, enabling medical practitioners to have specialized stem cells for use in neurodegenerative diseases with emphasis on ALS as the initial indication.
Contact Information
Website
www.qthera.comCorporate Office
- 417 Wakara Way
- Suite 3510
- Salt Lake City, UT 84108
- United States
Corporate Office
- 417 Wakara Way
- Suite 3510
- Salt Lake City, UT 84108
- United States
Q Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC | 01-Jan-2018 | Completed | Pre-Clinical Trials | |||
| 6. IPO | 04-Jun-2014 | Cancelled | Startup | |||
| 5. IPO | 16-Aug-2012 | Cancelled | Startup | |||
| 4. Grant | 17-May-2009 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 26-Feb-2008 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 18-May-2004 | $5M | $5M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2004 | Completed | Startup |
Q Therapeutics Comparisons
Industry
Financing
Details
Q Therapeutics Competitors (33)
One of Q Therapeutics’s 33 competitors is NanoSomiX, a Formerly VC-backed company based in Aliso Viejo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NanoSomiX | Formerly VC-backed | Aliso Viejo, CA | ||||
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| ReNetX Bio | Venture Capital-Backed | New Haven, CT | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Astrocyte Pharma | Venture Capital-Backed | Groton, CT |
Q Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Q Therapeutics Patents
Q Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190032010-A1 | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells | Inactive | 12-Nov-2009 | ||
| CA-2780541-A1 | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells | Active | 12-Nov-2009 | ||
| ES-2649396-T3 | Methods and compositions to expand, identify, characterize and improve the potency of mammalian glial restricted progenitor cells derived | Active | 12-Nov-2009 | ||
| CA-2780541-C | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells | Active | 12-Nov-2009 | ||
| AU-2010319680-B2 | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells | Active | 12-Nov-2009 | C12N5/0622 |
Q Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Q Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UpStart Ventures (Salt Lake City) | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| Invitrogen | Corporation | Minority | ||
| Salt Lake Life Science Angels | Angel Group | Minority | ||
| EPIC Ventures | Venture Capital | Minority |
Q Therapeutics Investments & Acquisitions (2)
Q Therapeutics’s most recent deal was a Joint Venture with MAGiQ Therapeutics. The deal was made on 23-Apr-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MAGiQ Therapeutics | 23-Apr-2018 | Joint Venture | Biotechnology | ||
| Grace 2 | 13-Oct-2011 | Merger/Acquisition | Holding Companies |
Q Therapeutics FAQs
-
When was Q Therapeutics founded?
Q Therapeutics was founded in 2004.
-
Where is Q Therapeutics headquartered?
Q Therapeutics is headquartered in Salt Lake City, UT.
-
What is the size of Q Therapeutics?
Q Therapeutics has 4 total employees.
-
What industry is Q Therapeutics in?
Q Therapeutics’s primary industry is Biotechnology.
-
Is Q Therapeutics a private or public company?
Q Therapeutics is a Private company.
-
What is Q Therapeutics’s current revenue?
The current revenue for Q Therapeutics is .
-
How much funding has Q Therapeutics raised over time?
Q Therapeutics has raised $20M.
-
Who are Q Therapeutics’s investors?
UpStart Ventures (Salt Lake City), U.S. Department of Health and Human Services, Invitrogen, Salt Lake Life Science Angels, and EPIC Ventures are 5 of 7 investors who have invested in Q Therapeutics.
-
Who are Q Therapeutics’s competitors?
NanoSomiX, CervoMed, ReNetX Bio, Alzheon, and Astrocyte Pharma are some of the 33 competitors of Q Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
